Kidney Cancer Weekly

December 22, 2025

Articles

Editor Selected Abstracts and Commentaries

Renal Cancer

Development and Validation of an Intratumor Heterogeneity-Based Prognostic Model for Clear Cell Renal Cell Carcinoma.

Advancements of investigational agents for renal cell carcinoma: what clinical progress have we seen in the last 5 years?

Clinical and Molecular Characterization of KRAS-Mutated Renal Cell Carcinoma.

Real-world efficacy and safety of pembrolizumab plus lenvatinib in patients with metastatic renal cell carcinoma: a multi-institutional retrospective study.

Estimated Glomerular Filtration Rate Equations Overestimate Renal Function Compared With Measured Glomerular Filtration Rate Using 24-Hour Urine Creatinine Clearance.

The global burden of kidney cancer: trends in mortality and incidence with predictions to 2025.

A retrospective chart review of UK patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab.

Renal cell tumours with papillary architecture: evolving concepts, classification and new emerging entities.

Molecularly defined renal cell carcinomas: practical approaches for surgical pathologists.

Diagnosing oncocytic renal tumours on renal mass biopsy; pathological concordance and the impact of evolving classification.

Outcomes of Patients with Localized Renal Cell Carcinoma on Immunosuppression Following Solid Organ Transplantation.

[99mTc]Tc-Sestamibi SPECT/CT for the Diagnosis of Kidney Tumours: A Multi-Centre Feasibility Study (MULTI-MIBI Study) - Beyond the Abstract

Cambridge kidney One-Stop Mass Investigation Clinic (CkOSMIC): A Nonrandomised Feasibility Study - Beyond the Abstract

CONNECT WITH US

Questions or Comments? Email us at

Digital Science Press, LLC
2011 Phaethon Lane,
Reno, NV 89523

You are receiving this email because you have chosen to receive emails from UroToday.

Add us to your address book View this email as a web page Forward to a colleague Manage your subscriptions Unsubscribe

Copyright ©2025 Digital Science Press, LLC